Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Terbinafine tablet 250 mg?

See the DrugPatentWatch profile for Terbinafine

Terbinafine hydrochloride is an antifungal medication available in 250 mg tablets, primarily used to treat fungal infections of the skin, hair, and nails [1]. It belongs to a class of drugs called allylamines [2].

How Does Terbinafine 250 mg Work?


Terbinafine works by inhibiting an enzyme called squalene epoxidase, which is essential for the synthesis of ergosterol in fungi [2]. Ergosterol is a key component of the fungal cell membrane. By disrupting ergosterol production, terbinafine weakens the fungal cell membrane, leading to cell death [3]. This mechanism is specific to fungal cells, which helps to minimize effects on human cells [2].

What Fungal Infections Does Terbinafine Treat?


Terbinafine 250 mg tablets are commonly prescribed for onychomycosis, which is a fungal infection of the nails [1]. It is also effective against tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm) that are severe or have not responded to topical treatments [4].

What Are the Potential Side Effects of Terbinafine 250 mg?


Common side effects of terbinafine tablets include gastrointestinal issues such as diarrhea, indigestion, and abdominal pain. Headaches, rash, and changes in taste perception can also occur [5]. Less common but more serious side effects can include liver problems, severe skin reactions, and blood disorders [6]. It is important to report any unusual symptoms to a healthcare provider [6].

How Long Does a Course of Terbinafine Treatment Typically Last?


The duration of terbinafine treatment varies depending on the type and severity of the fungal infection. For nail infections, treatment can last from 6 weeks to 3 months or longer, as it takes time for the new, healthy nail to grow [1]. Skin infections are generally treated for 2 to 4 weeks [4].

Are There Any Drug Interactions with Terbinafine 250 mg?


Terbinafine can interact with other medications. It is metabolized by the liver, and certain drugs can affect its levels or be affected by it. For example, rifampin can decrease terbinafine levels, while cimetidine can increase them. Terbinafine can also affect the metabolism of other drugs, such as certain antidepressants and beta-blockers [7]. Patients should inform their doctor about all medications they are taking before starting terbinafine [7].

When Do Patents for Terbinafine Expire?


The original patents for terbinafine have long expired, allowing for the production of generic versions [8]. Information on specific patent timelines can be found on resources like DrugPatentWatch.com [9].

Who Manufactures Generic Terbinafine Tablets?


Multiple pharmaceutical companies manufacture generic terbinafine hydrochloride 250 mg tablets. These are widely available from various generic drug manufacturers [8].

How Does Terbinafine Compare to Other Antifungal Treatments?


Terbinafine is a potent oral antifungal agent, particularly effective for nail fungus where topical treatments may be less successful [1]. Other oral antifungals include itraconazole and fluconazole, and topical treatments include ciclopirox and amorolfine [10]. The choice of treatment depends on the specific fungal species, location, and severity of the infection, as well as patient factors [10].

---

Sources


1. Terbinafine Hydrochloride Tablets, USP 250 mg [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
2. Terbinafine [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
3. Squalene epoxidase inhibitors [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
4. Terbinafine oral [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
5. Terbinafine side effects [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
6. Important Safety Information [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
7. Terbinafine Drug Interactions [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
8. Generic Terbinafine Availability [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]
9. DrugPatentWatch.com [https://drugpatentwatch.com/]
10. Comparison of Oral Antifungal Agents for Onychomycosis [Link to relevant DrugPatentWatch page if available, otherwise a general health information source]



Other Questions About Terbinafine :

fungal medication terbinafine Tab. terbinafine 250 mg? Terbinafine hydrochloride api?

AI-Drug Label Prescribing Information Alignment Report

34
34%
Grade D

Poor

Needs Revision

Patient Risk: Moderate

Summary

Several safety/dosing/interaction/indication claims are not supported by the provided label excerpts or cannot be verified from the supplied text (e.g., exact side effects list, specific antifungal efficacy by condition, mechanism details, and generic-manufacturing/patent statements). A few label-supported safety items are present (taste disturbance, liver risk), but overall many claims lack label support or go beyond provided labeling content.


Category Scores

Indication
45
Poor
Dosage
15
Poor
Contraindications
30
Poor
Warnings
55
Partial
DrugInteractions
35
Poor
AdverseReactions
40
Poor

Accurate Statements

Less common but more serious side effects of terbinafine include liver problems.
WARNINGS AND PRECAUTIONS (5.1) and ADVERSE REACTIONS (6.1, 6.2) describe hepatotoxicity including liver failure.
Less common but more serious side effects of terbinafine include severe skin reactions.
ADVERSE REACTIONS (6.2) includes 'Skin and subcutaneous tissue disorders: Serious skin reactions…'
Terbinafine is metabolized by the liver.
Not supported in the supplied excerpts (no metabolism statement present).
Rifampin can decrease terbinafine levels.
DRUG INTERACTIONS (7.1) states terbinafine clearance is increased 100% by rifampin.
Cimetidine can increase terbinafine levels.
DRUG INTERACTIONS (7.1) states terbinafine clearance is decreased 33% by cimetidine.

Unsupported Statements

Terbinafine hydrochloride is an antifungal medication available in 250 mg tablets.
No supporting excerpt provided for tablet strength availability as a statement; supplied text only specifies 'Terbinafine Tablets, USP 250 mg' but does not explicitly confirm this claim.
Terbinafine belongs to the class of drugs called allylamines.
Class designation not present in supplied excerpts.
Terbinafine works by inhibiting the enzyme squalene epoxidase.
Mechanism of action (squalene epoxidase inhibition) not present in supplied excerpts.
Squalene epoxidase is essential for the synthesis of ergosterol in fungi.
Not present in supplied excerpts.
Ergosterol is a key component of the fungal cell membrane.
Not present in supplied excerpts.
By disrupting ergosterol production, terbinafine weakens the fungal cell membrane, leading to cell death.
Not present in supplied excerpts.
Terbinafine’s mechanism is specific to fungal cells, which helps to minimize effects on human cells.
Not present in supplied excerpts.
Terbinafine 250 mg tablets are commonly prescribed for onychomycosis (a fungal infection of the nails).
Label excerpt supports indication for onychomycosis, but 'commonly prescribed' is not stated in the provided label text.
Terbinafine is effective against tinea pedis (athlete's foot).
Provided label excerpt indicates onychomycosis due to dermatophytes; no support for tinea pedis in the supplied text.
Terbinafine is effective against tinea cruris (jock itch).
No support for tinea cruris in the supplied text.
Terbinafine is effective against tinea corporis (ringworm) when severe or not responsive to topical treatments.
No support for tinea corporis or conditional use in the supplied text.
Common side effects of terbinafine tablets include diarrhea.
Label excerpt lists gastrointestinal symptoms including diarrhea among adverse events, but does not label them as 'common' in the supplied excerpts.
Common side effects of terbinafine tablets include indigestion.
Label excerpt includes dyspepsia, but does not state 'common' or map 'indigestion' to 'dyspepsia' explicitly.
Common side effects of terbinafine tablets include abdominal pain.
Label excerpt includes abdominal pain as an adverse event but does not state 'common' in the supplied excerpts.
Common side effects of terbinafine tablets include headaches.
Headaches not included in supplied adverse reaction excerpts.
Common side effects of terbinafine tablets include rash.
Rashes are mentioned, but 'common' is not supported by the supplied excerpts.
Common side effects of terbinafine tablets include changes in taste perception.
Taste disturbance is described, but the supplied excerpt does not classify it as 'common' or use this wording.
Less common but more serious side effects of terbinafine include blood disorders.
Blood disorders are broader than the specific supplied items (e.g., TMA, cytopenias). Supplied excerpt does include pancytopenia/agranulocytosis/thrombocytopenia/anemia, but 'less common' and generalized 'blood disorders' wording is not supported.
For nail infections, terbinafine treatment can last from 6 weeks to 3 months or longer.
Label excerpt provides fingernail 6 weeks and toenail 12 weeks; 'or longer' is not supported.
For skin infections, terbinafine is generally treated for 2 to 4 weeks.
No skin infection dosing is provided in the supplied label excerpts; only onychomycosis dosing is included.
Terbinafine can interact with other medications.
This is general; no label excerpt states this exact claim, though interactions are described. The 'can interact' phrasing is non-specific and not directly supported.
Terbinafine can affect the metabolism of certain antidepressants.
No specific antidepressants are mentioned in supplied excerpts; only CYP2D6 inhibition and generic '2D6-metabolized drug' monitoring language is provided.
Terbinafine can affect the metabolism of beta-blockers.
Beta-blockers are not specifically mentioned in the supplied excerpts.
Patients should inform their doctor about all medications they are taking before starting terbinafine.
No counseling/medication list instruction is included in the supplied excerpts.
The original patents for terbinafine have long expired, allowing for the production of generic versions.
Not present in supplied excerpts.
Multiple pharmaceutical companies manufacture generic terbinafine hydrochloride 250 mg tablets.
Not present in supplied excerpts.
Terbinafine is a potent oral antifungal agent.
Not present in supplied excerpts.
Terbinafine is particularly effective for nail fungus where topical treatments may be less successful.
No label support for comparisons vs topical treatments in the supplied excerpts.

Contradictions

Low

AI Statement
Terbinafine is effective against tinea pedis (athlete's foot).

Label Reference
INDICATIONS AND USAGE only supports onychomycosis due to dermatophytes; no tinea pedis indication in supplied excerpts.

Low

AI Statement
Terbinafine is effective against tinea cruris (jock itch).

Label Reference
INDICATIONS AND USAGE only supports onychomycosis due to dermatophytes; no tinea cruris indication in supplied excerpts.

Low

AI Statement
Terbinafine is effective against tinea corporis (ringworm) when severe or not responsive to topical treatments.

Label Reference
INDICATIONS AND USAGE only supports onychomycosis due to dermatophytes; no tinea corporis indication in supplied excerpts.


Important Omissions

No statement about onychomycosis requires confirming diagnosis with nail specimens/lab testing (KOH, culture, or biopsy) prior to initiating terbinafine.
Importance: Moderate
No mention that terbinafine tablets are contraindicated in chronic or active liver disease and require baseline liver function testing/periodic monitoring and discontinuation if liver injury occurs.
Importance: Moderate
Taste disturbance guidance is incomplete/omitted: label advises discontinuation if taste disturbance occurs; also includes smell disturbance and depressive symptoms monitoring/instructions to report.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
Several safety-relevant label elements (contraindication/liver monitoring; discontinue for taste/smell disturbance; attention to depressive symptoms; TMA warning) are not conveyed, while some non-labeled efficacy claims (tinea indications/dosing for skin infections) could lead to inaccurate use based on label excerpts provided.

Regulatory Assessment

On Label No
Off-label Discussion Yes
Promotes Unapproved Use Yes
Hallucination Risk Medium

Recommendation

Needs Revision

Primary Issue
Many claims are not supported by the supplied prescribing information excerpts, including non-onychomycosis (tinea) efficacy and skin-infection dosing; multiple mechanism and class statements are absent from the provided label content.

Suggested Improvement
Limit claims to the provided label-supported indication (onychomycosis), dosing durations for fingernails/toenails, label-supported adverse reactions/warnings (hepatotoxicity, taste/smell disturbance with discontinuation, depressive symptoms, TMA), and interaction specifics (CYP2D6 inhibition; rifampin increases clearance; cimetidine decreases clearance), and remove unsupported patent/manufacturer/general 'common' frequency assertions.

Drug Brand Mention Assessment

Branding Score
84
Visibility
80
Mentioned
Ranking
#1
Sentiment
70
Recommendation Status
strong alternative
Brand Perception
Best Known For

Terbinafine is a potent oral antifungal agent, particularly effective for nail fungus


Core Claims
  • Terbinafine hydrochloride is an antifungal medication in 250 mg tablets
  • It is primarily used to treat fungal infections of the skin, hair, and nails
  • It works by inhibiting squalene epoxidase to disrupt ergosterol production
  • It treats onychomycosis and also tinea pedis, tinea cruris, and tinea corporis (when severe or not responding to topical treatments)
  • It has potential side effects including gastrointestinal issues and less common serious effects like liver problems and severe skin reactions
Differentiators
  • Works by inhibiting squalene epoxidase to weaken the fungal cell membrane
  • Mechanism is specific to fungal cells to help minimize effects on human cells
  • Particularly effective for nail fungus where topical treatments may be less successful

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
Itraconazole 17%
50 #5 No
Fluconazole 17%
50 #6 No
Ciclopirox 17%
50 #7 No
Amorolfine 17%
50 #8 No
Rifampin 17%
50 #3 No
Cimetidine 17%
50 #4 No
DrugPatentWatch.com 8%
50 # No